Triglyceride and cardiovascular risk: A critical appraisal. - Wikidata - wikimedia - TriplyDB

Triglyceride and cardiovascular risk: A critical appraisal.

Triglyceride and cardiovascular risk: A critical appraisal.

http://www.wikidata.org/entity/Q37015549

about

Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics.Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.

P2860

Q39414910-CB879C6F-C726-453D-9DBA-C91B3A10C64C Q55176268-EC243276-7D0A-46C7-B272-7392066C52BE

P2860

Triglyceride and cardiovascular risk: A critical appraisal.

http://www.wikidata.org/entity/Q37015549

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Triglyceride and cardiovascular risk: A critical appraisal.

@en

Triglyceride and cardiovascular risk: A critical appraisal.

@nl

type

label

Triglyceride and cardiovascular risk: A critical appraisal.

@en

Triglyceride and cardiovascular risk: A critical appraisal.

@nl

prefLabel

Triglyceride and cardiovascular risk: A critical appraisal.

@en

Triglyceride and cardiovascular risk: A critical appraisal.

@nl

P1433

Q37015549-D3C384B2-B792-46DB-BEE3-08BC3438857C

P1476

Q37015549-FF6827B0-E9EB-4103-9EB6-2051009C2011

P2093

Q37015549-69C3D792-9C81-4815-8EDC-58DFA882CE98

Q37015549-9AF8901C-EE9E-43AA-86A6-88E5F554387A

P2860

Q37015549-012264AE-E63C-4F2B-88C8-ED2BA5757B48

Q37015549-09988E20-ED01-469E-B896-A6C8009A1B78

Q37015549-0A61E078-578D-4DF7-9198-4674483174AA

Q37015549-0F3BE82A-DD65-435E-8D45-92CCA8311943

Q37015549-16A447B7-69C1-42D5-9915-D057EECFDFAC

Q37015549-2135A35F-14F6-4B9B-A2B7-B94997012692

Q37015549-25F3370C-08CC-4E44-8F76-B6ED784B3945

Q37015549-295D52D6-04B8-49D2-9F0E-F49D868FD6A7

Q37015549-38C85ED1-4572-4FFD-A304-8A91F5BF0A00

Q37015549-394287A0-7F0B-4CE5-85FD-98B3F8B50FA6

P304

Q37015549-0307DAF3-F165-4AF1-949D-B5FA0179B491

P31

Q37015549-1e3cb73c-062d-45b4-9a36-1a9ea758f531

Q37015549-922B5949-D5A9-42B3-8177-5D06E885D14E

P356

Q37015549-FA9B11CD-124E-421C-A127-379E975C40CA

P433

Q37015549-CD823E9B-8402-437E-9BE3-C85E48C63589

P478

Q37015549-DF493AF2-9EF0-4962-91E7-DDCCE0482743

P577

Q37015549-03FCDA52-71D6-4F3C-95C7-157BD33DF714

P698

Q37015549-ECC91FE8-EF8A-493D-B36B-A5A4332C85E4

P921

Q37015549-610A6279-1FC1-4D97-B981-C5CC9B9F26DA

P932

Q37015549-F7E3EAF6-0470-42BC-9F39-70D158321CC7

P356

2230-8210.183460

P1433

Indian Journal of Endocrinology and Metabolism

P1476

Triglyceride and cardiovascular risk: A critical appraisal.

@en

P2093

Awadhesh Kumar Singh

http://www.w3.org/2001/XMLSchema#string

Ritu Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

P304

418-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2230-8210.183460

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27366705

http://www.w3.org/2001/XMLSchema#string

P921

P932

4911828

http://www.w3.org/2001/XMLSchema#string